What top creators are saying about Retatrutide(RETATRUTIDE)
Investigational Eli Lilly weight-management medication.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Based on 1 scored insight about Retatrutide.
Top creators covering Retatrutide (RETATRUTIDE)
The 1 sources with the most insights about Retatrutide on Kazuha.
Latest insights about Retatrutide (RETATRUTIDE)
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Yesterday
The host described retatrutide as a potential blockbuster and said Hims could potentially distribute it if it is approved and access is established.
Yesterday
The host described retatrutide as a potential blockbuster and said Hims could potentially distribute it if it is approved and access is established.
Discussed alongside Retatrutide (RETATRUTIDE)
Other assets that creators frequently mention in the same content as Retatrutide.
Frequently asked
Which podcasters and creators cover Retatrutide (RETATRUTIDE) the most?
The most active sources covering Retatrutide (RETATRUTIDE) on Kazuha are @BeatTheDenominator. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about Retatrutide (RETATRUTIDE) are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about Retatrutide (RETATRUTIDE) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside Retatrutide (RETATRUTIDE)?
Creators covering Retatrutide (RETATRUTIDE) most frequently also discuss COST, AAPL, HIMS, TSLA, FOUNDAYO. See the "Discussed alongside" section above for full asset pages.